Literature DB >> 31870844

Genomic and transcriptomic features of dermatofibrosarcoma protuberans: Unusual chromosomal origin of the COL1A1-PDGFB fusion gene and synergistic effects of amplified regions in tumor development.

Jan Köster1, Elsa Arbajian2, Björn Viklund3, Anders Isaksson3, Jakob Hofvander2, Felix Haglund4, Henrik Bauer5, Linda Magnusson2, Nils Mandahl2, Fredrik Mertens6.   

Abstract

The dermatofibrosarcoma protuberans family of tumors (DPFT) comprises cutaneous soft tissue neoplasms associated with aberrant PDGFBR signaling, typically through a COL1A1-PDGFB fusion. The aim of the present study was to obtain a better understanding of the chromosomal origin of this fusion and to assess the spectrum of secondary mutations at the chromosome and nucleotide levels. We thus investigated 42 tumor samples from 35 patients using chromosome banding, fluorescence in situ hybridization, single nucleotide polymorphism arrays, and/or massively parallel sequencing (gene panel, whole exome and transcriptome sequencing) methods. We confirmed the age-associated differences in the origin of the COL1A1-PDGFB fusion and could show that it in most cases must arise after DNA synthesis, i.e., in the S or G2 phase of the cell cycle. Whereas there was a non-random pattern of secondary chromosomal rearrangements, single nucleotide variants seem to have little impact on tumor progression. No clear genomic differences between low-grade and high-grade DPFT were found, but the number of chromosomes and chromosomal imbalances as well as the frequency of 9p deletions all tended to be greater among the latter. Gene expression profiling of tumors with COL1A1-PDGFB fusions associated with unbalanced translocations or ring chromosomes identified several transcriptionally up-regulated genes in the amplified regions of chromosomes 17 and 22, including TBX2, PRKCA, MSI2, SOX9, SOX10, and PRAME.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Dermatofibrosarcoma; Fusion; RNA-seq; SNP-array; Translocation mechanisms

Mesh:

Substances:

Year:  2019        PMID: 31870844     DOI: 10.1016/j.cancergen.2019.12.001

Source DB:  PubMed          Journal:  Cancer Genet


  4 in total

Review 1.  Malignant Superficial Mesenchymal Tumors in Children.

Authors:  Philippe Drabent; Sylvie Fraitag
Journal:  Cancers (Basel)       Date:  2022-04-26       Impact factor: 6.575

2.  Molecular profiling of gene fusions in soft tissue sarcomas by Ion AmpliSeqTM: a study of 35 cases.

Authors:  Rong Wei; Feng Gao; Zixin Zeng; Ziwei Gui; Yangwei Shang; Ningning Shen; Ziyue Wang; Weixia Han; Honghong Shen; Xin Li; Li E; Wenxia Ma; Chen Wang
Journal:  Transl Cancer Res       Date:  2022-03       Impact factor: 1.241

Review 3.  Application of Multi-Omics Approach in Sarcomas: A Tool for Studying Mechanism, Biomarkers, and Therapeutic Targets.

Authors:  Zijian Zou; Wei Sun; Yu Xu; Wanlin Liu; Jingqin Zhong; Xinyi Lin; Yong Chen
Journal:  Front Oncol       Date:  2022-07-08       Impact factor: 5.738

4.  Comprehensive analysis of transcriptome characteristics and identification of TLK2 as a potential biomarker in dermatofibrosarcoma protuberans.

Authors:  Xiao Zhang; Di Sun; Haiyan Zheng; Yamin Rao; Yuqi Deng; Xiao Liang; Jun Chen; Jun Yang
Journal:  Front Genet       Date:  2022-09-05       Impact factor: 4.772

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.